X
CAD
$1000,395,000
CannTrust
BOUGHT DEAL, JUNE 2018
Company Creation
Establishing new opportunities in healthcare
In very special situations, instead of providing services for fees, Bloom Burton™ partners with entrepreneurs and researchers to form new companies, leveraging all of our services and skills to accelerate their growth.
Bloom Burton™ leverages all of its services and skills:
- Advise on the company’s corporate and capital structure;
- Catalog and select the best target indications based on commercial, competitive and scientific considerations;
- Design the optimal international patent strategy;
- Design preclinical and clinical programs to produce valuable evidence for financing and partnering;
- Support the optimal regulatory strategy;
- Advise on the identification, license or acquisition of complimentary intellectual property and assets;
- Recruit the best management team and Board to help execute the Company’s strategy;
- Create marketing materials to inform, engage and transact with investors and partners;
- Raise seed and subsequent private and public capital; and
- Leverage the entire Bloom Burton platform to increase the exposure of the Company.
Browse recent incubations
X
Satellos Bioscience Inc.
Company Creation
2018
Satellos is a private, Canadian-based regenerative medicine company formed in 2018. The initial focus of the company is muscle regeneration, with a lead program in Duchenne Muscular Dystrophy.
Satellos Bioscience Inc.
X
NeuPath Health
Company Creation
2017
NeuPath is Canada's largest provider of chronic pain services. Through their network and brands, NeuPath is constantly expanding the scope of their services to serve communities.
NeuPath Health
X
Appili Therapeutics Inc.
Company Creation
2015
Appili Therapeutics Inc. was founded to advance the global fight against infectious disease by matching clearly defined patient needs with drug development programs that provide solutions to existing challenges patients, doctors, and society face in this critical disease space.
Appili Therapeutics Inc.
X
Grey Wolf Animal Health Inc.
Company Creation
2015
Grey Wolf Animal Health is a specialty animal health company focused on improving the lives and well-being of vets and pets in Canada and abroad. Founded in 2015 by Dr. Ian Sandler, their mission is to identify and bring to market products, solutions and services that meet the underserved needs of vets, pets and clinics across Canada.
Grey Wolf Animal Health Inc.
X
Triumvira Immunologics Inc.
Company Creation
2015
Triumvira is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Their proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.
Triumvira Immunologics Inc.
X
Qing Bile Therapeutics Inc.
Company Creation
2015
Qing Bile Therapeutics is a preclinical stage, private Canadian biotechnology company founded in 2015 based on research from Dr. Victor Ling’s laboratory at the University of British Columbia and BC Cancer Agency. Qing Bile has identified tetrahydroxylated bile acids (THBAs) to treat cholestatic and metabolic diseases with high unmet need.
Qing Bile Therapeutics Inc.
